Also categorized in Specialties - Cardiology:
FDA approves an Ebola vaccine, long in development, for the first time - Stat
x hide permanently

A Blood Sugar Biomarker Identifies Patients with Atherosclerosis & a Risk of Cardiovascular Events

Medical Xpress

Photo: JACC/ CNIC

MedicalXpress.com

The routine use of the glycosylated hemoglobin test to track blood sugar levels in the general population can identify individuals with more advanced atherosclerotic disease. Currently used in the diagnosis and management of diabetes, glycosylated hemoglobin can provide a useful estimate of atherosclerotic disease, and therefore of cardiovascular risk, in individuals without diabetes with or without possible prediabetes. This is the main finding of a study carried out by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC).

The advance heralded by the CNIC study is the use of this blood-sugar measure in apparently healthy ...